PhD defense – Shahinul Islam

Shahinul Islam will defend her PhD thesis on Tuesday 05th November 2019

Trial lecture: Tuesday 05th November 2019 at 14.30.
Topic: “The role of non-neutralizing antibodies in protection from influenza”
Place: Auditorium 4, BB-bygget, Jonas Lies vei 91

Public defense: Wednesday 06th November 2019 at 10.15.
Title of dissertation: “Live Attenuated Influenza Vaccine (LAIV) Immunization in Children and Adults: Lesson for Development of Universal Influenza Vaccine”
Place:  Auditorium, AHH, Haukelandsveien 28

1st opponent: Professor Anke Huckriede, University of Groningen, the Netherlands
2nd opponent: Researcher Craig Morton, Havforskningsinstituttet
3rd member of the comittee: Professor Silke Appel, Universitetet i Bergen

The defense will be led by professor Einar Thorsen.

New name

My name is Jonelle Dickow Villar and I am delighted to join the wonderful group of people at K2. My professional experience in Norway has focused on psychiatric nursing.  Last year I was fortunate to complete my master’s degree in the Epigenetics and Multiomics group with Stéphanie Le Hellard and the Martins group with Vidar Steen.  On July 1st this year I returned as a PhD student and will be continuing the work on identifying epigenetic modifications following different environmental exposures, including the antipsychotic drug olanzapine. You can find me on the 2nd floor or by email Jonelle.Villar@uib.no

 

 

New publications

Here are recent publications with contributions from K2 based on last week’s search on PubMed (and optionally articles that have not been included in previous lists). This time the list includes in total 8 recent publications. The entries appear in the order they were received from NCBI. If you have publications that are not included in this or previous lists, please send the references to Hege F. Berg.

Continue reading

The Nobel Prize in Physiology or Medicine 2019

The Nobel Prize in Physiology or Medicine 2019

The 2019 Nobel Prize in Physiology or Medicine was awarded to cancer researcher William G. Kaelin Jr, physician-scientist Sir Peter Ratcliffe and geneticist Gregg L. Semenza “for their discoveries of how cells sense and adapt to oxygen availability”. The ability of organisms to respond to changes in oxygen availability is of fundamental importance to life on earth. The prize-winning scientists have revealed how cells sense and respond to oxygen by switching genes on and off by oxygen-sensitive post-translational modification and the subsequent proteasomal degradation of hypoxia inducible factors. Among the applications of their discovery is a better understanding of how the body reacts when oxygen levels drop owing to exercise or stroke, and efforts to manipulate the response to slow the growth of oxygen-hungry cancer tumors.

Interestingly, in 2017 William G. Kaelin wrote in a commentary in Nature that many of the papers that he, Semenza and Ratcliffe wrote leading up to their discoveries “would be considered quaint, preliminary and barely publishable today”. “The goal of a paper seems to have shifted from validating specific conclusions to making the broadest possible assertions,” he argued, calling for a return to a focus on quality over impact.

What can be the causes for today’s inflation of impact and claims? One might be the emphasis funding agencies have on impact and translation of the results. Another can be that technological advances have made it easier to generate large amounts of research data, which can be published as online only supplements. Both these factors can encourage editors and reviewers to ask for extra experiments that can be byproducts, peripheral to the main conclusion or targeted to increase the impact.

In his comment in Nature in 2017, Kaelin concludes that he main question when reviewing a paper should be whether its conclusions are likely to be correct, not whether it would be important if it were true. Food for thought!

Have a nice week end!

(Norwegian) GERDA MEYER NYQUIST GULBRANSON & GERDT MEYER NYQUIST LEGAT

Legatet tildeler midler til hjerneforskning med fokus på uutforskede medfødte og ervervede sykdommer i nervesystemet, innen fagfeltene nevrologi, psykiatri og psykologi og humanitære formål rettet mot stiftelsen formål. Årlig utdelingsbeløp vil være opp mot en million kroner, og utdelingen vil begrenses til 2-3 prosjekter. For humanitære formål vil utdelingen årlig være i størrelsesorden totalt kr 60.000. Frist 1.12.19.

Mer informasjon her.

Reminder: Research data breakfast meeting

The University Library invites researchers and other employees to a research data breakfast Tuesday 22nd of October at the Medical Library!

Get breakfast and an introduction to open research data and how to prepare your data for storage and sharing. Sign up today!


08:30-08:40 Breakfast time!
08:40-09:00 Introduction to open research data
09:00-09:00 Break
09:10-09:30 How to prepare your data for sharing

Welcome!

New publications

Here are recent publications with contributions from K2 based on last week’s search on PubMed (and optionally articles that have not been included in previous lists). This time the list includes in total 5 recent publications. The entries appear in the order they were received from NCBI. If you have publications that are not included in this or previous lists, please send the references to Hege F. Berg.

Continue reading

Autumn has arrived

Following our tradition we will also this year have a K2 Junior retreat for PhD fellows and postdocs at K2, this year 4.-5. November in Myrkdalen, Voss. This year’s topic is creative thinking and stress management, and not to forget networking. A big thank you to the organization committee for this interesting program. It is not too late to register, the deadline is today 11.10.

This autumn we also have the possibility to improve our grant-writing skills. The research advisors arrange a seminar on the 7thNovember, 12:00-13:00 in the seminar room 7.1/2, Laboratory building. We have been so fortunate to show you examples of granted proposals from our researchers and will focus on excellence and impact sections of these. You will see examples of introduction, objectives and various types of impact. The difference between communication and dissemination is not so easy to delineate and we will therefore show examples of both. Finally, we have prepared an overview of upcoming deadlines and will also show examples of prizes and awards you can nominate yourself or others to. The seminar is relevant for everyone who at some point plans to submit a proposal for funding. The department will serve lunch so we kindly ask you to register here.

Talking about awards: the Department of Clinical Science wants to promote candidates for the Kong Olav V cancer research award. Suggestions can be sent to Silke by 4.11.2019.

And last but not least: the faculty’s candidate professor Bruce R. Zetter will be appointed honorary doctor at The Faculty of Medicine, and in connection with this will he give a guest lecture on Monday October 14that 14:15 (“RNA as a tool for cancer therapy”; Store Auditorium, main building Haukeland University hospital). There will be served tapas afterwards, so please register here.

(Norwegian) Dagens Medisin om Regine Åsen Jersins prosjekt på insulinresistens

UiB-stipendiat Regine Åsen Jersin presenterte sitt prosjekt om insulinresistens for 18 000 deltakere på kongressen EASD i Barcelona. 

Mekanismar i feittvevet kan vera med på å auka sjansen ein person har for å utvikla fedmerelaterte sjukdommar. Studien har funne at redusert transport av aminosyra serine inn i feittceller fører til auka cellestress, meir feittlagring og insulinresistens.

Les mer om saken her.

(Norwegian) Informasjon om tjenesteportal og felles servicesenter

UiB har anskaffet og planlegger nå innføring av en tjenesteportal (enterprise service management system). Nederlandske TOPdesk er valgt som leverandør i en anskaffelse som er felles for BOTT-universitetene.

Fra 7. oktober vil det ikke være mulig registrere nye saker i Issue-tracker. All oppretting og håndtering av nye saker vil skje i tjenesteportalen (TOPdesk). Issue-tracker vil fortsatt være aktiv etter 7. oktober for å avslutte pågående saker og av arkivhensyn.

For mer informasjon se her.

(Norwegian) Endelig nedstengning av Mi Side

Som kjent tok Mitt UiB over for Mi Side som UiBs læringsstøttesystem i 2016. Etter at bruken av Mi side ble faset ut, har systemet fortsatt vært tilgjengelig for lesing og nedlasting av filer for tidligere brukere. Mi Side stenges ned for godt ved nyttår. Etter 31. desember 2019 kan man altså ikke regne med å få tilgang til innholdet.

Hva angår informasjon som ligger der i dag:

  1. Arkivverdig dokumentasjon – som pensumlister, emne- og studieprogrambeskrivelser vil flyttes til Studiekvalitetsbasen. UiB tar ansvar for dette.
  2. Den enkelte ansatte må selv ta ansvar for å laste ned presentasjoner, oppgaver, dokumenter, lenker og annet lærestoff som ikke er bevart annet sted.

Mer info her.

PhD defense – Øystein Fløtten

Øystein Fløtten will defend her PhD thesis on Thursday 17th October 2019

Trial lecture: Thursday 17th October 2019 at 10.30.
Topic: “Behandling av lungekreft – et paradigmeskifte? Hva er de viktigste endringer i behandlingsmuligheter vi har sett de senere årene og hva kan vi vente oss fremover?”
Place: Auditorium 1, BB-bygget, Jonas Lies vei 91

Public defense: Thursday 17th October 2019 at 12.30.
Title of dissertation: “Simplifying treatment of advanced non-small cell lung cancer- Regimen, route of administration, and patient preferences”
Place:  Auditorium 1, BB-bygget, Jonas Lies vei 91

1st opponent: Ph.d. Seppo Langer, Rigshospitalet, København
2nd opponent: Postdoktor Vilde Haakensen, Oslo Universitetssykehus
3rd member of the comittee: Førsteamanuensis Astrid Olsnes Kittang, Universitetet i Bergen

The defense will be led by professor Jon Hardie.

New publications

Here are recent publications with contributions from K2 based on last week’s search on PubMed (and optionally articles that have not been included in previous lists). This time the list includes in total 3 recent publications. The entries appear in the order they were received from NCBI. If you have publications that are not included in this or previous lists, please send the references to Hege F. Berg.

Continue reading

About RETTE

Data protection and privacy for individuals is the right to privacy and the right to decide on your own personal data. GDPR Article 30 strengthens the requirements for overview and control. UiB has a legal responsibility to safeguard the privacy of employees, students, and research participants. In order to meet this responsibility, RETTE is now being implemented to ensure compliance with and increased competence for key legislation in research and education.

RETTE stands for risk and compliance (Risiko og ETTErlevelse ) in research projects, and is UiB’s system for monitoring and control of the processing of personal data in research and student projects. The system will also have an overview and control of tasks and projects related to quality assurance of patient care and teaching, and projects related to learning analysis purposes.

RETTE will be available for registration of information on projects that process personal data at UiB from October. The Faculty of Medicine is the faculty that first gains access to the RETTE. Registration, follow-up and confirmation of projects will be carried out in the administrative line with RETTE arranging for responsibility for confirmation from the project manager, the department management, and the faculty management on their project portfolio.

RETTE aims to increase the competence in the privacy rights for students and staff, and should be a tool for the institutes at UiB so that they can be sure that personal data is processed in accordance with current legislation.

In practical terms, RETTE is a website linked to UiB.no/personvernportalen where no installation or special technical skills are required to use the system. The system consists of a registration module for students and staff, and an admin module for the use of institutes, faculties and management.

There are role-based approaches in RETTE, and the Dean and Head of Department designate and select faculty and department heads for RETTE within the system. At K2, it is research leader Silke Appel who will be operationally responsible for monitoring projects in RETTE.

Health research projects must first seek REK. Approved projects are then transferred to RETTE from Cristin, and researchers will be told to provide supplementary information in the RETTE. Projects requiring exemption from the duty of confidentiality must first seek REK, and follow the procedure in RETTE. Completing the form in RETTE is stated to take approx. 10 minutes. For more information, see https://www.uib.no/personvern.

It is great that UiB takes the Privacy Act and GDPR seriously. RETTE seems to be a tool that is practical and useful for the purpose.

Happy fall holidays!

Pål Rasmus Njølstad

(Norwegian) Pedagogisk kompetanseheving: Påmelding til MEDDID601 – våren 2020 – er nå åpnet!

Til deg som er vitenskapelig tilsatt men ikke har kommet med på Universitetets ordinære pedagogikkurs; her er sjansen til å få både formell og reell pedagogisk kompetanse!

Det er nå åpnet for påmelding til kurset «Innføring i medisinsk- og helsefaglig didaktikk» (5 studiepoeng) for VÅREN 2020.

Les mer om emnet her.
Påmelding her.

De 27 deltagerne som tok kurset da det ble avholdt første gang var godt fornøyd, du kan lese litt mer om kurset her.

Hilsen Jone Trovik, undervisningsleder K2

(Norwegian) Reminder: Nytt om immunologi, stamcellebehandling og kreftmedisin

Biomedical Network har gleden av å invitere til møte med fokus på immunologi, stamcellebehandling og kreftmedisin. Arrangementet er en møteplass for alle som ønsker å ta del i utviklingen av pasientenes helsetjeneste. Vel møtt!

Tid: 16. Oktober, kl. 13:30

Sted: Bikuben, Haukeland universitetssjukehus

Påmelding her.

Program finner du her.

Kontaktpersoner:
Jens Reigstad, VIS, jre@visinnovasjon.no
Marie Borg, VIS,  mbo@visinnovasjon.no

Om Biomedical Network:
Biomedical Network er et nettverkssamarbeid mellom Helse Bergen, Universitetet i Bergen (UiB), Legemiddelindustriforeningen (LMI) og VIS. Nettverket tar sikte på å bli en felles plattform for innovasjon og prosjektutvikling på tvers av akademiske, offentlige og private aktører, og er støttet av Norges Forskningsråd (NFR).

(Norwegian) Informasjon om stengning for biltrafikk mellom Sentralblokken og Glassblokkene i uke 43

I heile veke 43 blir vegen nord for Sentralblokka stengd for innkøyring av bilar. Dette må gjerast på grunn av at store stålelement til Glasblokkene skal heisast inn på byggeplassen.

Campusbussen vil ikke ha stoppested i Sentralblokken nord i uke 43. Følg med på campusbussens nettside for nærmere informasjon om midlertidig stoppested.

Mer info finner du her.